Coming Soon

« Company Overview
600
2015-07-01 to 2015-07-31
SME Support
Awaiting Public Project Summary
600
2015-07-01 to 2015-07-31
SME Support
Awaiting Public Project Summary
600
2015-07-01 to 2015-07-31
SME Support
Awaiting Public Project Summary
600
2015-07-01 to 2015-07-31
SME Support
Awaiting Public Project Summary
600
2015-07-01 to 2015-07-31
SME Support
Awaiting Public Project Summary
600
2015-07-01 to 2015-07-31
SME Support
Awaiting Public Project Summary
600
2015-07-01 to 2015-07-31
SME Support
Awaiting Public Project Summary
600
2015-07-01 to 2015-07-31
SME Support
Awaiting Public Project Summary
600
2015-07-01 to 2015-07-31
SME Support
Awaiting Public Project Summary
600
2015-07-01 to 2015-07-31
SME Support
Awaiting Public Project Summary
600
2015-07-01 to 2015-07-31
SME Support
Awaiting Public Project Summary
600
2015-07-01 to 2015-07-31
SME Support
Awaiting Public Project Summary
600
2015-07-01 to 2015-07-31
SME Support
Awaiting Public Project Summary
600
2015-07-01 to 2015-07-31
SME Support
Awaiting Public Project Summary
600
2015-07-01 to 2015-07-31
SME Support
Awaiting Public Project Summary
600
2015-07-01 to 2015-07-31
SME Support
Awaiting Public Project Summary
600
2015-07-01 to 2015-07-31
SME Support
Awaiting Public Project Summary
600
2015-07-01 to 2015-07-31
SME Support
Awaiting Public Project Summary
600
2015-07-01 to 2015-07-31
SME Support
Awaiting Public Project Summary
53,794
2015-05-01 to 2016-04-30
GRD Development of Prototype
Corium Solutions Ltd has demonstrated proof of concept for a low toxicity anti-fungal treatment known as Micro-Fresh which is effective in preventing moulds developing on plastered or plasterboard walls in humid environments. The inhalation of the spores from moulds is known to be harmful and can lead to asthma and other serious pulmonary conditions such as aspergilliosis. The purpose of this project is to demonstrate the effectiveness of Micro-Fresh treatments on representative brick & plaster and block & plasterboard walls inoculated with Aspergillus fumigatus and Aspergillus niger in a large environmental chamber at 24 deg C and 95% humidity. Such conditions are known to promote the growth of Aspergillus sp.
19,943
2013-12-01 to 2014-03-31
GRD Proof of Market
The UK is one of the few countries that permit healthcare workers not only to wear their uniforms to and from work but also to launder them at home; however this could be considered to be a source of infection. Whilst NHS guidelines recommend high temperature washing or disinfecting under controlled conditions it is difficult to carry this out in most domestic washing machines. Corium has developed an anti-pathogen treatment for leather products that has been trialled to treat healthcare uniforms and has the potential to inhibit pathogen development in textiles on a long term basis using the low temperature washing cycle of a domestic washer in the range 30-40 deg C. The purpose of the grant application is to analyse the market potential for this innovation
46,947
2013-10-01 to 2014-09-30
GRD Proof of Concept
Corium Solutions Ltd has developed a low toxicity anti-fungal treatment which it is believed will be effective in preventing moulds developing on plastered or plasterboard walls in humid environments. The inhalation of the spores from moulds is known to be harmful and lead to asthma and other serious pulmonary conditions such as aspergilliosis. The purpose of this proof of concept project is to conduct trials for formulation development and carry out a market review.